Close Menu

NEW YORK – RenalytixAI on Tuesday reported $400,000 in pharmaceutical service revenue for Q2 2021, compared to none a year ago.

RenalytixAI reported a net loss of $9.1 million, or $0.12 per share, for the recently completed quarter compared to a net loss of $4.7 million, or $0.08 per share a year ago.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.